Raymond James Financial Services Advisors’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-220
| Closed | -$1.74K | – | 3489 |
|
|
2024
Q2 | $1.74K | Buy |
+220
| New | +$1.74K | ﹤0.01% | 3378 |
|
|
2020
Q4 | – | Sell |
-14,299
| Closed | -$548K | – | 2987 |
|
|
2020
Q3 | $548K | Buy |
14,299
+260
| +2% | +$9.96K | ﹤0.01% | 1898 |
|
|
2020
Q2 | $543K | Sell |
14,039
-2,000
| -12% | -$77.4K | ﹤0.01% | 1870 |
|
|
2020
Q1 | $481K | Buy |
16,039
+144
| +0.9% | +$4.32K | ﹤0.01% | 1573 |
|
|
2019
Q4 | $1.8M | Buy |
15,895
+1,020
| +7% | +$116K | 0.01% | 1216 |
|
|
2019
Q3 | $469K | Sell |
14,875
-518
| -3% | -$16.3K | ﹤0.01% | 1942 |
|
|
2019
Q2 | $659K | Sell |
15,393
-65
| -0.4% | -$2.78K | ﹤0.01% | 1741 |
|
|
2019
Q1 | $842K | Sell |
15,458
-960
| -6% | -$52.3K | ﹤0.01% | 1551 |
|
|
2018
Q4 | $488K | Sell |
16,418
-4,544
| -22% | -$135K | ﹤0.01% | 1685 |
|
|
2018
Q3 | $964K | Buy |
20,962
+5,392
| +35% | +$248K | ﹤0.01% | 1488 |
|
|
2018
Q2 | $338K | Buy |
15,570
+2,268
| +17% | +$49.2K | ﹤0.01% | 2155 |
|
|
2018
Q1 | $509K | Buy |
13,302
+104
| +0.8% | +$3.98K | ﹤0.01% | 1705 |
|
|
2017
Q4 | $765K | Sell |
13,198
-170
| -1% | -$9.85K | ﹤0.01% | 1465 |
|
|
2017
Q3 | $882K | Buy |
13,368
+421
| +3% | +$27.8K | 0.01% | 1389 |
|
|
2017
Q2 | $1.09M | Buy |
12,947
+86
| +0.7% | +$7.27K | 0.01% | 1209 |
|
|
2017
Q1 | $1.78M | Buy |
+12,861
| New | +$1.78M | 0.01% | 884 |
|